We are live on ! Find out more
NIM

Northeast Investment Management Portfolio holdings

AUM $2.71B
1-Year Est. Return 25.45%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+25.45%
3 Year Est. Return
+93.39%
5 Year Est. Return
+114.23%
10 Year Est. Return
+466.62%
AUM
$994M
AUM Growth
+$21.1M
Cap. Flow
+$3.98M
Cap. Flow %
0.4%
Top 10 Hldgs %
27.23%
Holding
159
New
6
Increased
56
Reduced
71
Closed
4

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$4.26M
2
CHD icon
Church & Dwight Co
CHD
+$2.04M
3
META icon
Meta Platforms (Facebook)
META
+$2.03M
4
BMY icon
Bristol-Myers Squibb
BMY
+$2.01M
5
SBUX icon
Starbucks
SBUX
+$1.94M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$4.38M
2
SF
Stifel
SF
+$2.76M
3
ABT icon
Abbott
ABT
+$2M
4
NVO
Novo Nordisk
NVO
+$1.91M
5
DIS icon
Walt Disney
DIS
+$1.38M

Sector Composition

Rank Sector Weight
1 Healthcare 17.49%
2 Financials 12.74%
3 Industrials 12.38%
4 Consumer Discretionary 10.08%
5 Technology 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WAB icon
151
Wabtec
WAB
$49.7B
$209K 0.02%
2,981
-453
-13% -$35.2K
EPD icon
152
Enterprise Products Partners
EPD
$82.2B
$207K 0.02%
+7,076
New +$190K
YUM icon
153
Yum! Brands
YUM
$39.7B
$206K 0.02%
3,448
– –
HYB
154
DELISTED
New America High Income Fund, Inc.
HYB
$97K 0.01%
11,385
– –
DS
155
DELISTED
Drive Shack Inc.
DS
$83K 0.01%
+18,175
New +$80.6K
BIIB icon
156
Biogen
BIIB
$30.6B
– –
-1,657
Closed -$431K
C icon
157
Citigroup
C
$227B
– –
-5,125
Closed -$214K
STT icon
158
State Street
STT
$51.3B
– –
-3,795
Closed -$222K
TEVA icon
159
Teva Pharmaceuticals
TEVA
$42.1B
– –
-4,010
Closed -$215K
3 4 5 6
7

Similar funds

NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

Northeast Investment Management's Q2 2016 Portfolio in Review

As of Q2 2016, Northeast Investment Management held 159 positions worth $994M, up 2.2% from $973M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Northeast Investment Management's Q2 2016 filing shows 6 new, 56 increased, 71 reduced and 4 closed positions. Its largest new stake was Becton Dickinson: 7,355 shares worth $1.22M. The largest sale was Novartis, an estimated $4.38M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Industrials.

  • Northeast Investment Management's largest Q2 2016 buy was Becton Dickinson: 7,355 shares worth $1.22M.
  • Northeast Investment Management added most to Thermo Fisher Scientific in Q2 2016, an estimated $4.26M increase.
  • Northeast Investment Management's biggest Q2 2016 reduction was Novartis, cutting an estimated $4.38M.
  • Northeast Investment Management fully exited Biogen in Q2 2016, selling an estimated $431K.
  • Northeast Investment Management's ten largest holdings make up 27% of its $994M portfolio in Q2 2016.
  • Northeast Investment Management opened 6 new positions and closed 4 in Q2 2016.
  • Northeast Investment Management's portfolio value rose 2.2% quarter-over-quarter to $994M.

Based on Northeast Investment Management's 13F filing for Q2 2016, filed 2 Aug 2016.